The First OTC Syphilis Test: Clinical Performance and Impact

25/10/2025 36 min Episodio 104
The First OTC Syphilis Test: Clinical Performance and Impact

Listen "The First OTC Syphilis Test: Clinical Performance and Impact"

Episode Synopsis

Treponema pallidum, the causative agent of syphilis, has been around for what seems like forever, causing major outbreaks throughout the millennia and continuing to spread at high rates, globally, into today. When it comes to diagnostic testing, some tests like RPR and VDRL have stood the test of time, having been implemented in the late 1930s and 1940s, and are now used in combination with contemporary methods like EIAs and chemiluminescent assays as the reference standard method to diagnosis syphilis cases. New approaches to screening and diagnosis are needed, however, to increase test access and ultimately case identification and treatment.  Guests: Dr. Kevin Clark Dr. Jody Berry Links:  Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Romney Humphries, Ph.D., D(ABMM).  Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Become an ASM member to receive up to 50% off publishing fees when you publish in JCM or any of the ASM journals. Sign up at asm.org/joinasm.